Background: Although autoimmune gastritis (AIG) is generally considered relatively
| INTRODUCTION
Patients with autoimmune gastritis (AIG) are positive for either or both anti-parietal cell antibody (APCA) and anti-intrinsic factor antibody. They experience severe atrophic change in the gastric corpus and achlorhydria, and are at higher risk for developing gastric carcinoid and gastric cancer. 1 To date, however, AIG has been considered relatively rare.
In Japan, patients with gastritis and some other lesions alone who are diagnosed as positive for Helicobacter pylori infection by a test such as the 13 C-urea breath test ( 13 C-UBT) can undergo eradication therapy under the health insurance system. Standard eradication therapy in Japan consists of a two-step regimen. The first-line regimen consists of a proton pump inhibitor (PPI) or vonoprazan, amoxicillin and clarithromycin, while the second consists of a PPI or vonoprazan, amoxicillin and metronidazole.
Although this two-step strategy clears infection in most patients, it nevertheless fails in some. The hospital of Hamamatsu University School of Medicine (Hamamatsu, Japan) includes an outpatient unit dedicated to patients with H. pylori infection and related disorders. Many patients with two or more episodes of eradication failure in other hospitals or clinics visit this unit. Some have experienced repeated eradication failure with a variety of regimens. We call these multiple eradication failures "Endless eradication." We recently identified several patients with AIG among the "Endless eradication" group. Having noted an index case of multiple failed "eradications" in a 13 C-UBT-positive patient subsequently shown to have gastric atrophy, we speculated that bacterial overgrowth with urease-producing organisms might be a cause of false-positive results in 13 C-UBT in patients with AIG. In other words, in patients with AIG, gastric acid secretion is strongly inhibited, to the point of achlorhydria, which in turn allows enteric bacteria and bacteria from the oral cavity to colonise the stomach.
Some of these bacteria are positive for urease activity, which likely renders 13 C-UBT findings positive at low levels. Most of these patients are then misdiagnosed as having been continuously infected with H. pylori even after several intensive antimicrobial therapies. We also consider that AIG is relatively frequent in patients who have failed H. pylori eradication two or more times based on 13 C-UBT.
Against this background, we prospectively studied the incidence of AIG in patients diagnosed as refractory to standard eradication therapy. 
| ME TH ODS

| Subjects
| Diagnosis of autoimmune gastritis
Patients with severe atrophic gastritis (O-II-III) in the gastric corpus and positivity for APCA were diagnosed as having AIG.
| Statistics
All numerical values are expressed as means AE SD or medians with ranges. In this model, values lower than detectability (ie, <3)
were entered as zero. Subjects with a titre of anti-H. 
| Incidence of AIG in patients with different eradication histories
Of 404 patients, 43 were diagnosed as having AIG. Of 220 patients in the multiple failure group, 40 (18.2%, 95% CI = 13.3%-23.9%)
were diagnosed with AIG, while of the 47 patients in the single failure group, one (2.1%; 95% CI = 0.0%-11.3%) was diagnosed with AIG. Of 137 patients in the treatment-naive group, only two patients (1.5%; 95% CI = 0.0%-5.2%) were diagnosed with AIG.
| Differences in clinical characteristics between AIG and non-AIG patients
Demographic clinical characteristics of patients with and without AIG are summarised in Table 2 . The mean age of AIG patients was 64.9 AE 8.0 y, which was significantly higher than that of non-AIG patients (58.3 AE 12.9 y) (P < 0.001).
Serum levels of PG I and PG II and PG I/PG II ratios were significantly lower in the AIG than non-AIG patients (Figure 1 A, B, C) . Figure 3A ). In contrast, the medians of atrophy and chronic inflammation of the gastric antrum were higher in the seropositive AIG patients (Figure 3E, H ). There were no statistically significant differences in other scores between the seropositive and seronegative groups (Figure 3 B, C, D, F and G).
| DISCUSSION
In this study, we found that around one-fifth of patients who were diagnosed with failed eradication of H. pylori based on 13 C-UBT at least twice had AIG. Furthermore, most patients with AIG
were infected with urease-positive bacteria in the stomach, most high. 15 Nevertheless, no regimen has attained an eradication rate of 100% in a relatively large study. Because the incidence of AIG is not in fact so low and the condition is sometimes difficult to diagnose, the failure of a strong eradication regimen to attain a perfect eradication rate may be due to the inclusion of patients with AIG as study subjects.
The mechanism by which autoimmune gastritis develops has not been clarified, but several reports indicate a role for H. pylori infection. [16] [17] [18] [19] [20] Nevertheless, some cases of AIG are not related to H. pylori infection. 21 AIG is involved in polyglandular autoimmune syndrome (PAS). However, H. pylori can infect the gastric mucosa of AIG patients with PAS, and some AIG patients are infected with H. pylori whereas others are not. In this study, titres of anti-H. pylori
IgG antibody were not zero in some AIG patients, indicating that some patients with AIG had exposure to H. pylori. Interestingly, some of our AIG patients who were seronegative for H. pylori had more severe atrophy in the corpus, while those who were seropositive had more severe atrophy and chronic inflammation in the antrum (Figure 3 ). We therefore assume that AIG seropositive for H. pylori The results of our study should be interpreted within the context of the following limitations. First, this was the single centre study. A multicentre study is required to elucidate the incidence of AIG in the real world. Second, sample size was small. Third, histological examination was not performed in all patients. | 375 testing for APCA. Fourth, most patients had previously undergone eradication therapy, and it was therefore unclear whether they were originally infected with H. pylori. Finally, we did not measure gastric juice pH, and could not confirm achlorhydria in each patient.
In conclusion, this study shows that patients with AIG are some- 
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